Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1).

Alexandrakis M, Letourneau R, Kempuraj D, Kandere-Grzybowska K, Huang M, Christodoulou S, Boucher W, Seretakis D, Theoharides TC.

Eur J Haematol. 2003 Dec;71(6):448-54.

PMID:
14703695
2.

The isoflavone genistein inhibits proliferation and increases histamine content in human leukemic mast cells.

Alexandrakis MG, Kyriakou DS, Kempuraj D, Huang M, Boucher W, Seretakis D, Theoharides TC.

Allergy Asthma Proc. 2003 Sep-Oct;24(5):373-7.

PMID:
14619339
3.

Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1).

Alexandrakis MG, Kyriakou DS, Seretakis D, Boucher W, Letourneau R, Kempuraj D, Theoharides TC.

Int J Immunopathol Pharmacol. 2003 Jan-Apr;16(1):43-7.

PMID:
12578730
4.

Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.

Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC.

J Pharmacol Exp Ther. 1999 Mar;288(3):1349-56.

PMID:
10027877
5.

A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process.

Pang X, Alexacos N, Letourneau R, Seretakis D, Gao W, Boucher W, Cochrane DE, Theoharides TC.

J Pharmacol Exp Ther. 1998 Oct;287(1):307-14.

PMID:
9765351
6.

Changing seasonality of mortality from coronary heart disease.

Seretakis D, Lagiou P, Lipworth L, Signorello LB, Rothman KJ, Trichopoulos D.

JAMA. 1997 Sep 24;278(12):1012-4.

PMID:
9307350

Supplemental Content

Loading ...
Support Center